Share on PinterestExperimental vaccine prevents colorectal, pancreatic cancer recurrence in early trial. Image credit: Alina Kostrytsia/Getty Images Gastrointestinal cancers — including pancreatic, and colorectal cancers — account for about 26% of all cancers worldwide. Both pancreatic and colorectal cancers are susceptible to gene mutations called KRAS mutations, which can make these cancers harder to treat.... Read More














:max_bytes(150000):strip_icc()/HDC-GettyImages-668641904-9179dc9fe60446d8b4d8a08fbffcf46d.jpg?w=600&resize=600,400&ssl=1)




Recent Comments